Ultrasound-guided percutaneous renal biopsy-induced accessory renal artery bleeding in an amyloidosis patient
Open Access
- 11 December 2012
- journal article
- case report
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 176
Abstract
Ultrasound-guided percutaneous renal biopsy is an important technique for diagnosis of glomerular diseases, and the biopsy-induced life-threatening bleeding rarely happens. Primary systemic amyloidosis is a rare disease which may lead to organ dysfunction including arterial stiffness. The accessory renal artery is a kind of renal vascular variation which goes into the renal parenchyma directly or via the renal hilum. Here we reported a rare case of percutaneous renal biopsy-induced accessory renal artery life-threatening bleeding in a renal amyloidosis patient, and our experience of successful rescue in this patient.Keywords
This publication has 18 references indexed in Scilit:
- Is there a link between diabetic glomerular injury and crescent formation? A case report and literature reviewDiagnostic Pathology, 2012
- Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature reviewDiagnostic Pathology, 2011
- Immunohistochemical comparison of CD5, lambda, and kappa expression in primary and recurrent buccal Mucosa-associated lymphoid tissue (MALT) lymphomasDiagnostic Pathology, 2011
- Advances in the Treatment of AmyloidosisNew England Journal of Medicine, 2007
- Light-Chain (AL) AmyloidosisClinical Journal of the American Society of Nephrology, 2006
- Outcome of autologous stem cell transplantation for AL amyloidosis in the UKBritish Journal of Haematology, 2006
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisAmerican Journal of Hematology, 2005
- Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of AmyloidosisAmyloid, 2005
- A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and ColchicineNew England Journal of Medicine, 1997
- Secondary amyloidosis (AA)Journal of Internal Medicine, 1992